The employment of leukotriene antagonists in cutaneous diseases belonging to allergological field

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Nettis, Eustachio ^a   D'Erasmo, Maddalena ^a   Di Leo, Elisabetta ^a   Calogiuri, Gianfranco ^b   Montinaro, Vincenzo ^c   Ferrannini, Antonio ^a   Vacca, Angelo ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b Pneumologic Hospital A Galateo   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CETIRIZINE; CLARITHROMYCIN; CORTICOSTEROID; DESLORATADINE; FEXOFENADINE; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LEVOCETIRIZINE; LORATADINE; MONTELUKAST; PLACEBO; PRANLUKAST; ZAFIRLUKAST; ZILEUTON;

ANTIINFLAMMATORY ACTIVITY; ATOPIC DERMATITIS; BINDING AFFINITY; CHRONIC URTICARIA; CLINICAL TRIAL; COLD URTICARIA; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; ERYTHEMA; EXUDATE; HUMAN; INFLAMMATION; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; TREATMENT RESPONSE;

ACETATES; ANIMALS; HUMANS; HYPERSENSITIVITY; LEUKOTRIENE ANTAGONISTS; QUINOLINES; SKIN DISEASES; TOSYL COMPOUNDS;

EID: 78349236257     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/628171     Document Type: Review

References (53)

1. Spector S., Tan R. A., Antileukotrienes in chronic urticaria Journal of Allergy and Clinical Immunology 1998 101 4 572
2. Kgi M. K., Leukotriene receptor antagonistsa novel therapeutic approach in atopic dermatitis? Dermatology 2001 203 4 280 283
3. Geha R. S., Meltzer E. O., Desloratadine: a new, nonsedating, oral antihistamine Journal of Allergy and Clinical Immunology 2001 107 4 751 762
4. Soter N. A., Lewis R. A., Corey E. J., Austen K. F., Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin Journal of Investigative Dermatology 1983 80 2 115 119
5. Schwartz L. B., Mast cells and their role in urticaria Journal of the American Academy of Dermatology 1991 25 1 190 204
6. Iversen L., Kristensen P., Gron B., Ziboh V. A., Kragballe K., Human epidermis transforms exogenous leukotriene A4 into peptide leukotrienes: possible role in transcellular metabolism Archives of Dermatological Research 1994 286 5 261 267
7. Maxwell D. L., Atkinson B. A., Spur B. W., Lessof M. H., Lee T. H., Skin responses to intradermal histamine and leukotrienes C4, D4, and E4 in patients with chronic idiopathic urticaria and in normal subjects Journal of Allergy and Clinical Immunology 1990 86 5 759 765
8. Wedi B., Novacovic V., Koerner M., Kapp A., Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expressionInhibitory effects of anti-inflammatory drugs Journal of Allergy and Clinical Immunology 2000 105 3 552 560
9. Farber E. M., Nickoloff B. J., Recht B., Fraki J. E., Stress, symmetry, and psoriasis: possible role of neuropeptides Journal of the American Academy of Dermatology 1986 14 2 305 311
10. Talbot S. F., Atkins P. C., Goetzl E. J., Zweiman B., Accumulation of leukotriene C4 and histamine in human allergic skin reactions The Journal of Clinical Investigation 1985 76 2 650 656
11. Ruzicka T., Ring J., Enhanced releasability of prostaglandin E2 and leukotrienes B4 and C4 from leukocytes of patients with atopic eczema Acta Dermato-Venereologica 1987 67 6 469 475
12. ymar K., Aksnes L., Increased levels of urinary leukotriene E4 in children with severe atopic eczema/dermatitis syndrome Allergy 2005 60 1 86 89
13. Capra V., Ambrosio M., Riccioni G., Rovati G. E., Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities Current Medicinal Chemistry 2006 13 26 3213 3226
14. Zuberbier T., Asero R., Bindslev-Jensen C., Walter Canonica G., Church M. K., Gimnez-Arnau A., Grattan C. E. H., Kapp A., Merk H. F., Rogala B., Saini S., Snchez-Borges M., Schmid-Grendelmeier P., Schnemann H., Staubach P., Vena G. A., Wedi B., Maurer M., EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria Allergy 2009 64 10 1417 1426
15. Zuberbier T., Asero R., Bindslev-Jensen C., Walter Canonica G., Church M. K., Gimnez-Arnau A. M., Grattan C. E. H., Kapp A., Maurer M., Merk H. F., Rogala B., Saini S., Snchez-Borges M., Schmid-Grendelmeier P., Schnemann H., Staubach P., Vena G. A., Wedi B., EAACI/GALEN/EDF/WAO guideline: management of urticaria Allergy 2009 64 10 1427 1443
16. Ellis M. H., Successful treatment of chronic urticaria with leukotriene antagonists Journal of Allergy and Clinical Immunology 1998 102 5 876 877
17. Kaplan A. P., Chronic urticaria and angioedema The New England Journal of Medicine 2002 346 3 175 179
18. Asero R., Tedeschi A., Riboldi P., Griffini S., Bonanni E., Cugno M., Severe chronic urticaria is associated with elevated plasma levels of D-dimer Allergy 2008 63 2 176 180
19. Finn A. F. Jr., Kaplan A. P., Fretwell R., Qu R., Long J., A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria Journal of Allergy and Clinical Immunology 1999 104 5 1071 1078
20. Lippert U., Mller A., Welker P., Artuc M., Henz B. M., Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists Experimental Dermatology 2000 9 2 118 124
21. Vena G. A., Cassano N., Buquicchio R., Ventura M. T., Antiinflammatory effects of H1-antihistamines: clinical and immunological relevance Current Pharmaceutical Design 2008 14 27 2902 2911
22. Godse K. V., Oral montelukast monotherapy is ineffective in chronic idiopathic urticaria: a comparison with oral cetirizine Indian Journal of Dermatology, Venereology and Leprology 2006 72 4 312 314
23. Bensch G., Borish L., Leukotriene modifiers in chronic urticaria Annals of Allergy, Asthma and Immunology 1999 83 4 348
24. Hani N., Hartmann K., Casper C., Peters T., Schneider L.-A., Hunzelmann N., Scharffetter-Kochanek K., Improvement of cold urticaria by treatment with the leukotriene receptor antagonist montelukast Acta Dermato-Venereologica 2000 80 3 229
25. Berkun Y., Shalit M., Successful treatment of delayed pressure urticaria with montelukast Allergy 2000 55 2 203 204
26. Ohnishi-Inoue Y., Mitsuya K., Horio T., Aspirin-sensitive urticaria: provocation with a leukotriene receptor antagonist British Journal of Dermatology 1998 138 3 483 485
27. Pacor M. L., Di Lorenzo G., Corrocher R., Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid Clinical and Experimental Allergy 2001 31 10 1607 1614
28. Di Lorenzo G., Luisa Pacor M., Mansueto P., Esposito Pellitteri M., Lo Bianco C., Ditta V., Martinelli N., Battista Rini G., Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria Journal of Allergy and Clinical Immunology 2004 114 3 619 625
29. Bagenstose S. E., Levin L., Bernstein J. A., The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results Journal of Allergy and Clinical Immunology 2004 113 1 134 140
30. Nettis E., Dambra P., D'Oronzio L., Loria M. P., Ferrannini A., Tursi A., Comparison of montelukast and fexofenadine for chronic idiopathic urticaria Archives of Dermatology 2001 137 1 99 100
31. Nettis E., Colanardi M. C., Paradiso M. T., Ferrannini A., Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study Clinical and Experimental Allergy 2004 34 9 1401 1407
32. Erbagci Z., The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study Journal of Allergy and Clinical Immunology 2002 110 3 484 488
33. Norris G. J., Sullivan T. J., Leukotrienes and cytokines in steroid dependent urticaria Journal of Allergy and Clinical Immunology 1998 101 128
34. Sanada S., Tanaka T., Kameyoshi Y., Hide M., The effectiveness of montelukast for the treatment of anti-histamine- resistant chronic urticaria Archives of Dermatological Research 2005 297 3 134 138
35. Asero R., Tedeschi A., Lorini M., Leukotrine receptor antagonists in chronic urticaria Allergy 2001 56 5 456 457
36. Reimers A., Pichler C., Helbling A., Pichler W. J., Yawalkar N., Zafirlukast has no beneficial effects in the treatment of chronic urticaria Clinical and Experimental Allergy 2002 32 12 1763 1768
37. Nettis E., Pannofino A., Cavallo E., Ferrannini A., Tursi A., Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria Journal of Allergy and Clinical Immunology 2003 112 1 212 213
38. Nettis E., Colanardi M. C., Soccio A. L., Ferrannini A., Vacca A., Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study British Journal of Dermatology 2006 155 6 1279 1282
39. Berkun Y., Shalit M., Successful treatment of delayed pressure urticaria with montelukast Allergy 2000 55 2 203 204
40. Asero R., Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria Journal of Allergy and Clinical Immunology 2003 111 5 1095 1098
41. Asero R., Tedeschi A., Riboldi P., Griffini S., Bonanni E., Cugno M., Coagulation cascade and fibrinolysis in patients with multiple-drug allergy syndrome Annals of Allergy, Asthma and Immunology 2008 100 1 44 48
42. Goel A., Prasad D., Oral monteleukast in urticaria induced by nonsteroidal anti-inflammatory drugs Journal of the European Academy of Dermatology and Venereology 2007 21 9 1275 1276
43. Perez C., Sanchez-Borges M., Capriles E., Pretreatment with montelukast blocks NSAID-induced urticaria and angioedema Journal of Allergy and Clinical Immunology 2001 108 6 1060 1061
44. Asero R., Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria Annals of Allergy, Asthma and Immunology 2000 85 2 156 157
45. Dahln S.-E., Malmstrm K., Nizankowska E. W. A., Dahln B., Kuna P., Kowalski M., Lumry W. R., Picado C., Stevenson D. D., Bousquet J., Pauwels R., Holgate S. T., Shahane A., Zhang J., Reiss T. F., Szczeklik A., Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial American Journal of Respiratory and Critical Care Medicine 2002 165 1 9 14
46. Nettis E., Pannofino A., Fanelli M., Ferrannini A., Tursi A., Efficacy and tolerability of montelukast as a therapeutic agent for severe atopic dermatitis in adults Acta Dermato-Venereologica 2002 82 297 320
47. Yanase D. J., David-Bajar K., The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis Journal of the American Academy of Dermatology 2001 44 1 89 93
48. Pei A. Y. S., Chan H. H. L., Leung T. F., Montelukast in the treatment of children with moderate-to-severe atopic dermatitis: a pilot study Pediatric Allergy and Immunology 2001 12 3 154 158
49. Carucci J. A., Washenik K., Weinstein A., Shupack J., Cohen D. E., The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis Archives of Dermatology 1998 134 7 785 786
50. Angelova-Fischer I., Tsankov N., Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast Acta Dermatovenerologica Alpina, Pannonica et Adriatica 2005 14 3 115 119
51. Capella G. L., Frigerio E., Altomare G., A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults European Journal of Dermatology 2001 11 3 209 213
52. Friedmann P. S., Palmer R., Tan E., Ogboli M., Barclay G., Hotchkiss K., Berth-Jones J., A double-blind, placebo-controlled trial of montelukast in adult atopic eczema Clinical and Experimental Allergy 2007 37 10 1536 1540
53. Silverberg N. B., Paller A. S., Leukotriene receptor antagonists are ineffective for severe atopic dermatitis Journal of the American Academy of Dermatology 2004 50 3 485 486